17.04.25 |
Novo Nordisk Market-Perform |
Bernstein Research |
|
17.04.25 |
Novo Nordisk Underperform |
Jefferies & Company Inc. |
|
17.04.25 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
17.04.25 |
A.P. Moeller - Maersk A-S Underperform |
Bernstein Research |
|
16.04.25 |
Novo Nordisk Overweight |
Barclays Capital |
|
08.04.25 |
Novo Nordisk Buy |
UBS AG |
|
07.04.25 |
Novo Nordisk Market-Perform |
Bernstein Research |
|
07.04.25 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
07.04.25 |
Novo Nordisk Buy |
UBS AG |
|
04.04.25 |
Novo Nordisk Buy |
UBS AG |
|
04.04.25 |
A.P. Moeller - Maersk A-S Underweight |
JP Morgan Chase & Co. |
|
03.04.25 |
Novo Nordisk Market-Perform |
Bernstein Research |
|
03.04.25 |
Novo Nordisk Buy |
Goldman Sachs Group Inc. |
|
03.04.25 |
Novo Nordisk Underperform |
Jefferies & Company Inc. |
|
31.03.25 |
Novo Nordisk Buy |
UBS AG |
|
28.03.25 |
Novo Nordisk Buy |
UBS AG |
|
28.03.25 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
28.03.25 |
Novo Nordisk Buy |
UBS AG |
|
27.03.25 |
A.P. Moeller - Maersk A-S Sell |
Deutsche Bank AG |
|
24.03.25 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
24.03.25 |
Novo Nordisk Hold |
Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
|
21.03.25 |
Novo Nordisk Buy |
UBS AG |
|
17.03.25 |
Novo Nordisk Buy |
UBS AG |
|
14.03.25 |
Novo Nordisk Buy |
UBS AG |
|
12.03.25 |
Novo Nordisk Underperform |
Jefferies & Company Inc. |
|
11.03.25 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
11.03.25 |
Novo Nordisk Underperform |
Jefferies & Company Inc. |
|
11.03.25 |
Novo Nordisk Buy |
Goldman Sachs Group Inc. |
|
10.03.25 |
Novo Nordisk Buy |
UBS AG |
|
10.03.25 |
Novo Nordisk Market-Perform |
Bernstein Research |
|
10.03.25 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
10.03.25 |
Novo Nordisk Market-Perform |
Bernstein Research |
|
07.03.25 |
Novo Nordisk Buy |
UBS AG |
|
04.03.25 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
03.03.25 |
Novo Nordisk Buy |
UBS AG |
|
26.02.25 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
25.02.25 |
Novo Nordisk Market-Perform |
Bernstein Research |
|
24.02.25 |
Novo Nordisk Buy |
UBS AG |
|
20.02.25 |
Novo Nordisk Market-Perform |
Bernstein Research |
|
19.02.25 |
Novo Nordisk Buy |
Goldman Sachs Group Inc. |
|